Presence of West Nile Virus in Horses (Equus caballus) in two wetlands in the province of the Ríos, 2007 to 2009
DOI:
https://doi.org/10.53591/rug.v111i2.457Keywords:
West Nile Virus, ELISA, NTRPAbstract
In orden to know the presence of West Nile Virus (WNV) in horses of Ecuador. Was investigated in: The Abras de Mantequilla and Jauneche. For the theme of this research is first conducted a census of the equine population in the areas studied, which was 273 animals. Then the samples were taken, later to be processed on the thread of Virology, National Institute of Hygiene and Tropical Medicine “Leopoldo Izquieta Perez” for the determination of antibodies to WNV by ELISA. The reactive samples were sent to the CDC in Puerto Rico to be confirmed by neutralization test by reducing the number of plates (NTRP). Of the 189 samples tested, 15 were reactive by ELISA of which 5 were confirmed by (NTRP).
References
Barriga G, Arumir C, Mercado F. (2002): Actualidades sobre la fiebre del Nilo Occidental. Rev Mex Patol Clin 49 (4): pp 203 – 211. México
Burke D, Monath T. (2001): Flaviviruses. En: Knippe DM, Howley PM, editores. Fields Virology. Lippincott Williams & Wilkins; pp. 1043 – 1125. EEUU.
Centers for Disease Control and Prevention. (1999): Outbreak of West Nile like viral encephalitis New York. Morb Mortal Wkly Rep; 48: pp. 845 – 849. EEUU.
Campbell G, Marfin A, Lanciotti R, Gubler D. (2002): West Nile Virus. Lancet Infect Dis; 2: pp 519 – 529. EEUU
Harrison T. (2002): West Nile Encephalitis. J Pediatr Health Care; 16: pp. 278 – 281. EEUU.
Izaguirre R, López L, Richard J, Mesa J, Herrera O. (2003): Infección por Virus del Nilo Occidental. Revista de Especialidad Médico-Quirúrgicas; 8 (2): pp. 5 – 7. México.
Javier CASTILLO-OLIVARES*, James WOOD. (2004): West Nile virus infection of horses. Vet. Res. 35; pp. 467–483. EEUU.
Morales M, Barrandeguy M, Fabbri C, García J, Vissani A, Trono K, et al. (2006). West Nile Virus isolation from equines in Argentina Emerging infectious diseases; 12 (10): dispacht.
Mattar S, Edwards E, Laguado J, Gonzalez M, Alvarez J, Komar N. (2005): West Nile Virus in Colombian horses. Emerging infectious diseases; 11 (9): pp. 1497 – 1498. Colombia.
Mandel G, Bennet J, Dolin R (2000): Principles and Practice of Infectious Diseases. 5th Ed. Philadelphia: Churchill Livingstone, EEUU.
Marfin A, Gubler D. (2001): West Nile Encephalitis: an emerging disease in the United Status. CID; 33: pp. 1713 – 1719.
OPS/OMS/CDC. (2006): Taller sobre Vigilancia y Diagnóstico del Virus del Nilo Occidental. Pergamino, pp. 50. Argentina
Petersen L, Marfin A. (2002): West Nile Virus: a primer for the clinician. Ann Intern Med 2002; 137: pp. 173 – 179. EEUU.
Soler D, Vera J. (2007): Intento de Detección del Virus del Oeste del Nilo en aves silvestres de San Andrés Isla, Colombia. Universidad Nacional de Colombia – Asociación de Veterinarios de Vida Silvestre. Colombia.
Sampson B, Ambrosi C, Charlot A, Reiber K, Veress J, Anmbrustmacher V. (2000): The pathology of human West Nile Virus infection. Hum Pathol; 31: pp. 527 – 531. EEUU
Valles X, Sánchez F. West Nile virus: el virus de la fiebre del Oeste del Nilo. Enf. Emerg. 2000; 2 (4): 232 – 238. España.
West Nile Virus IgM Capture ELISA. PanBio. EEUU.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0. International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

























